These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
282 related articles for article (PubMed ID: 3595441)
1. Pharmacological investigation of a new anti-arrhythmic agent, GYKI-23 107. Varró A; Rabloczky G; Jaszlits L; Kürthy M; Zubovics Z; Toldy L Drugs Exp Clin Res; 1987; 13(1):21-8. PubMed ID: 3595441 [TBL] [Abstract][Full Text] [Related]
2. General pharmacological studies on N-(2,6-dimethylphenyl)-8-pyrrolizidineacetamide hydrochloride hemihydrate. 1st communication: effect on the central nervous system. Hirotsu I; Kihara T; Nakamura S; Hattori Y; Hatta M; Kitakaze Y; Takahama K; Hashimoto Y; Miyata T; Ishihara T Arzneimittelforschung; 1988 Oct; 38(10):1398-409. PubMed ID: 3196380 [TBL] [Abstract][Full Text] [Related]
3. Antifibrillatory effect of GYKI-23107 in induced ventricular vulnerability by local cooling and programmed stimulation in canine models. Szatmary LJ; Rabloczky G; Kurthy M; Frater E; Solti F Acta Med Hung; 1988; 45(2):221-9. PubMed ID: 3247245 [TBL] [Abstract][Full Text] [Related]
5. Inhibition of sympathetic nervous system by mexiletine, an antiarrhythmic agent, and its antagonism against ouabain. Kitagawa H; Takeda F; Kohei H Arzneimittelforschung; 1985; 35(1A):356-9. PubMed ID: 4039173 [TBL] [Abstract][Full Text] [Related]
8. Effects of the new class I antiarrhythmic agent Ro 22-9194, (2R)-2-amino-N-(2,6-dimethylphenyl)-N-[3-(3-pyridyl)propyl]propionamide D-tartrate, on ischemia- and reperfusion-induced arrhythmias in dogs: involvement of thromboxane A2 synthase inhibitory activity. Murakami M; Kinukawa M; Kanazawa T; Maruyama K; Miyagi M; Miyata H; Ujiie A J Pharmacol Exp Ther; 1996 Nov; 279(2):877-83. PubMed ID: 8930195 [TBL] [Abstract][Full Text] [Related]
9. [Experimental anti-arrhythmic effects of a new beta-adrenergic receptor blocking agent, dl-l-(tert. butylamino)-3-[(2-propinyloxy)phenoxy]2-propanol hydrochloride (dl Kö 1400-Cl)]. Matsubara I; Hashimoto K; Katano Y; Tsukada T; Matsuda H Nihon Yakurigaku Zasshi; 1976 Jul; 72(5):557-71. PubMed ID: 11153 [TBL] [Abstract][Full Text] [Related]
10. [Effects of lorcainide, a new antiarrhythmic agent, on experimental cardiac arrhythmias]. Fukuda H; Goto M; Kondo M; Uchigasaki T; Sekino Y Nihon Yakurigaku Zasshi; 1983 Feb; 81(2):115-26. PubMed ID: 6852683 [TBL] [Abstract][Full Text] [Related]
11. Antiarrhythmic and hemodynamic effects of prifuroline. Benharkate M; Plassard G; Legeai J; Worcel M Arzneimittelforschung; 1986 Dec; 36(12):1761-7. PubMed ID: 3566836 [TBL] [Abstract][Full Text] [Related]
12. Antiarrhythmic effect of newly synthesized compound 44Bu on model of aconitine-induced arrhythmia -- compared to lidocaine. Bartosova L; Novak F; Bebarova M; Frydrych M; Brunclik V; Opatrilova R; Kolevska J; Mokry P; Kollar P; Strnadova V; Suchy P Eur J Pharmacol; 2007 Dec; 575(1-3):127-33. PubMed ID: 17706639 [TBL] [Abstract][Full Text] [Related]
13. Indecainide: effects on arrhythmias, electrophysiology, and cardiovascular dynamics. Holland DR; Lacefield WB; Gonzales CR; Johnston SR; Turk JA J Cardiovasc Pharmacol; 1989 Sep; 14(3):454-61. PubMed ID: 2476626 [TBL] [Abstract][Full Text] [Related]
14. Antiarrhythmic and cardiovascular profiles of the fused indole compound (3aR,12R,12aR,12bS)-12-amino-2,3,3a,4,11,12,12a,12b-octahydro-10-hydrox yisoquino [2,1,8-lma]carbazol-5(1H)-one hydrochloride 1.5 hydrate. Yorikane R; Mizuno H; Itoh Y; Koike H; Miyake S; Shiga H; Kumakura S; Fukami M; Shimoji Y; Hashimoto T Arzneimittelforschung; 1991 Nov; 41(11):1130-6. PubMed ID: 1810258 [TBL] [Abstract][Full Text] [Related]
15. [Comparative study of the anti-arrhythmic activity of mexiletine and lidocaine in ventricular hyperkinetic arrhythmias]. Rolli A; Bonatti V; Finardi A; Favaro L; Botti G G Ital Cardiol; 1981; 11(4):468-76. PubMed ID: 6169578 [TBL] [Abstract][Full Text] [Related]
16. Antiarrhythmic action of the new calcium antagonist [1,2,5-trimethyl-4-phenyl-4-beta-(N-cyanoethyl-N-4'-methoxybenzyl) -ethylamino]piperidine dihydrochloride. Alexanian AR; Arutyunian NS; Galoyan AA Arzneimittelforschung; 1996 Dec; 46(12):1110-3. PubMed ID: 9006783 [TBL] [Abstract][Full Text] [Related]
17. Anti-arrhythmic action of dilazep. Action on experimental arrhythmias induced by g-strophanthin (ouabain), epinephrine and aconitine. Sano N; Kawada M; Fukutomi Y Arzneimittelforschung; 1974 Nov; 24(11A Suppl):1893-8. PubMed ID: 4141624 [No Abstract] [Full Text] [Related]
18. [Comparison of antiarrhythmic effects of IHC-72 (an iodonium-72), lidocaine and verapamil]. Ji GJ; Zhao DH; Liu DQ; Sheng BH Yao Xue Xue Bao; 1992; 27(6):407-11. PubMed ID: 1442066 [TBL] [Abstract][Full Text] [Related]
19. N-(2,6-Dimethylphenyl)-8-pyrrolizidineacetamide hydrochloride hemihydrate (SUN 1165): a new potent and long-acting antiarrhythmic agent. Aisaka K; Hidaka T; Inomata N; Hamasaki S; Ishihara T; Morita M Arzneimittelforschung; 1985; 35(8):1239-45. PubMed ID: 4074441 [TBL] [Abstract][Full Text] [Related]
20. [Mexiletine in treatment of chronic ventricular refractary arrhythmias (author's transl)]. Bellocci F; Ansalone G; Scabbia E; Santarelli P; Lucente M; Affinito V; Loperfido F; Zecchi P G Ital Cardiol; 1981; 11(4):488-97. PubMed ID: 6169580 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]